These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404 [TBL] [Abstract][Full Text] [Related]
5. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856 [TBL] [Abstract][Full Text] [Related]
6. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Kashyap SR; Diab DL; Baker AR; Yerian L; Bajaj H; Gray-McGuire C; Schauer PR; Gupta M; Feldstein AE; Hazen SL; Stein CM Obesity (Silver Spring); 2009 Sep; 17(9):1696-701. PubMed ID: 19360015 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. Hyogo H; Yamagishi S; Maeda S; Kimura Y; Ishitobi T; Chayama K Dig Liver Dis; 2012 Jun; 44(6):492-6. PubMed ID: 22265683 [TBL] [Abstract][Full Text] [Related]
9. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485 [TBL] [Abstract][Full Text] [Related]
10. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605 [TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. Sterling RK; Smith PG; Brunt EM J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409 [TBL] [Abstract][Full Text] [Related]
12. The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population. Zelber-Sagi S; Ratziu V; Zvibel I; Goldiner I; Blendis L; Morali G; Halpern Z; Oren R Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):262-9. PubMed ID: 22246329 [TBL] [Abstract][Full Text] [Related]
13. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483 [TBL] [Abstract][Full Text] [Related]
14. UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity. Labruna G; Pasanisi F; Nardelli C; Tarantino G; Vitale DF; Bracale R; Finelli C; Genua MP; Contaldo F; Sacchetti L J Endocrinol Invest; 2009 Jun; 32(6):525-9. PubMed ID: 19474520 [TBL] [Abstract][Full Text] [Related]
15. Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression? Durazzo M; Niro G; Premoli A; Morello E; Rizzotto ER; Gambino R; Bo S; Musso G; Cassader M; Pagano G; Floreani A J Gastroenterol; 2009; 44(5):476-82. PubMed ID: 19301087 [TBL] [Abstract][Full Text] [Related]
16. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160 [TBL] [Abstract][Full Text] [Related]
17. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis]. Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475 [TBL] [Abstract][Full Text] [Related]
18. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease]. Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347 [TBL] [Abstract][Full Text] [Related]